coronavirus
envelop
positivesens
singlestrand
rna
virus
nucleocapsid
helic
symmetri
coronavirus
wide
identifi
caus
respiratori
intestin
infect
human
outbreak
sever
acut
respiratori
syndrom
sar
guangdong
china
sar
determin
caus
sarscov
emerg
market
civet
sold
decad
later
world
wit
anoth
outbreak
form
middl
east
respiratori
syndrom
mer
caus
merscov
middl
east
research
still
investig
underli
mechan
pathogen
develop
effect
therapeut
strategi
mer
world
wit
deadliest
outbreak
form
caus
coronaviru
outbreak
name
due
resembl
sarscov
sarscov
infect
ciliat
bronchial
epitheli
cell
typeii
pneumocyt
angiotensinconvert
enzym
receptor
mer
infect
uncili
bronchial
epitheli
cell
typeii
pneumocyt
use
dipeptidyl
peptidas
also
known
receptor
mechan
associ
infecti
clear
howev
structur
analysi
suggest
like
enter
human
cell
receptor
newli
emerg
viru
much
greater
similar
sarscov
merscov
thu
sarscov
may
caus
pathogenesi
similar
mechan
transmiss
sarscov
human
report
market
civet
merscov
dromedari
camel
similarli
newli
emerg
also
appear
transmit
human
market
wild
anim
sold
howev
zoonot
sourc
transmiss
yet
clear
accord
previou
report
aforement
three
coronavirus
thought
origin
bat
sinc
first
epidem
sar
pathogen
coronavirus
harm
thousand
peopl
worldwid
consid
advers
outcom
current
epidem
develop
effect
therapeut
strategi
necessari
cope
lack
effect
drug
high
mortal
rate
potenti
viru
caus
epidem
review
focu
origin
evolut
pathogen
sarscov
merscov
also
discuss
therapeut
option
given
import
current
scenario
outbreak
wuhan
china
review
use
prepar
futur
outbreak
continu
pathogen
infect
class
novel
coronavirus
virul
human
coronavirus
member
subfamili
coronavirina
famili
coronavirida
order
nidoviral
contain
four
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
gamma
deltacoronavirus
gener
infect
bird
although
caus
infect
mammal
wherea
alpha
betacoronavirus
known
harm
human
anim
virus
sarscov
betacoronaviru
alphacoronaviru
betacoronaviru
alphacoronaviru
betacoronaviru
merscov
betacoronaviru
caus
infect
human
howev
betacoronavirus
import
group
compris
highli
pathogen
virus
human
includ
merscov
sarscov
highli
pathogen
mer
sar
coronavirus
origin
bat
howev
origin
newli
emerg
remain
debat
investig
reveal
sarscov
strain
detect
market
civet
transmit
horsesho
bat
virus
found
phylogenet
relat
sarscov
bat
china
europ
southeast
asia
africa
addit
genom
sequenc
sarscov
strain
isol
human
highli
similar
bat
howev
variat
found
among
gene
gene
sequenc
encod
bind
fusion
protein
dispens
protein
replic
respect
nevertheless
genet
region
sarscov
bat
contain
major
variat
compar
sarscov
human
differ
strain
merscov
obtain
camel
found
similar
isol
human
except
variat
among
genom
region
furthermor
genom
sequencingbas
studi
reveal
merscov
strain
human
phylogenet
relat
bat
strain
ident
genom
protein
structur
except
protein
addit
recombin
analysi
gene
encod
reveal
merscov
origin
exchang
genet
element
coronavirus
camel
bat
although
zoonot
sourc
confirm
genom
sequenc
exhibit
close
related
ident
two
batderiv
sarslik
coronavirus
phylogenet
analysi
reveal
genet
distinct
sarscov
merscov
howev
homolog
model
reveal
sarscov
similar
receptorbind
domain
structur
despit
amino
acid
variat
key
residu
includ
absenc
protein
fluctuat
number
amino
acid
protein
contrast
primari
proteas
highli
conserv
sarscov
overal
ident
observ
suggest
bat
sourc
origin
anim
sold
wuhan
seafood
market
might
repres
intermedi
host
facilit
emerg
viru
human
emerg
sarscov
guangdong
provinc
china
rapidli
spread
around
globe
novemb
epidem
pneumonia
high
rate
transmiss
peopl
occur
guangdong
china
follow
subsequ
outbreak
hong
kong
hong
kong
total
peopl
contract
infect
within
week
exposur
infect
patient
gener
ward
hospit
overal
sarscov
infect
peopl
caus
fatal
differ
countri
end
epidem
later
june
patient
infect
merscov
develop
sever
pneumonia
die
jeddah
saudi
arabia
analysi
cluster
nosocomi
case
jordan
april
confirm
merscov
caus
outbreak
spread
merscov
continu
beyond
middl
east
caus
report
infect
individu
case
fatal
report
global
decemb
cluster
patient
atyp
pneumonia
report
local
health
facil
wuhan
china
decemb
rapid
respons
team
dispatch
chines
center
diseas
control
prevent
china
cdc
conduct
epidemiolog
etiolog
investig
patient
found
epidemiolog
link
wet
anim
wholesal
seafood
market
wuhan
china
later
infecti
agent
respons
atyp
pneumonia
confirm
report
coronaviru
caus
first
fatal
earli
januari
first
week
outbreak
sever
case
report
countri
includ
usa
japan
iran
south
korea
infect
rapidli
spread
across
globe
wuhan
china
therefor
chines
author
implement
sever
strategi
includ
massiv
lockdown
wuhan
suspens
transport
wuhan
control
spread
accord
situat
report
publish
websit
caus
confirm
case
death
around
globe
howev
caus
confirm
case
death
insid
mainland
china
alon
februari
report
death
iran
second
countri
china
bear
highest
fatal
due
infect
spread
iran
pose
higher
risk
pandem
middl
east
south
asian
countri
decemb
januari
analysi
growth
rate
epidem
gave
basic
reproduct
number
mean
patient
spread
infect
individu
estim
valu
sar
around
howev
sar
success
control
isol
patient
moreov
mer
rang
saudi
arabia
south
korea
consid
lower
valu
rapid
increas
suspect
well
confirm
case
may
infer
via
viral
transmiss
fecalor
rout
aerosol
format
moreov
asymptomat
person
thought
potenti
sourc
infect
may
caus
rapid
spread
asymptomat
spread
may
one
reason
control
strategi
base
isol
patient
fulli
success
overcom
problem
complet
quarantin
necessari
allow
infect
individu
develop
symptom
without
spread
viru
randomli
thu
direct
indirect
contact
infect
individu
easili
identifi
isol
clinic
featur
associ
patient
infect
sarscov
merscov
rang
mild
respiratori
ill
sever
acut
respiratori
diseas
mer
sar
patient
later
stage
develop
respiratori
distress
renal
failur
pneumonia
appear
frequent
manifest
infect
character
primarili
fever
cough
dyspnea
bilater
infiltr
chest
imag
period
infect
appear
symptom
vari
gener
thought
day
howev
research
group
guangzhou
medic
univers
report
incub
period
day
famili
cluster
infect
onset
fever
respiratori
symptom
occur
approxim
day
presumpt
exposur
diagnost
test
primarili
done
public
health
laboratori
delay
test
result
need
administr
oversight
test
nation
region
level
well
time
need
transport
specimen
high
volum
test
need
region
rapid
test
wide
avail
event
epidem
highlevel
test
facil
region
hospit
commerci
laboratori
need
addit
commerci
avail
test
undergon
regulatori
approv
sever
test
valid
public
health
author
includ
china
germani
thailand
japan
unit
state
technic
guidanc
feb
test
revers
transcriptas
pcr
rtpcr
test
use
primer
probe
design
detect
varieti
target
genom
although
design
valid
current
limit
inform
avail
relat
perform
test
sensit
specif
test
wide
known
might
detect
relat
coronavirus
sarscov
addit
util
differ
specimen
type
detect
virus
known
result
test
multipl
specimen
type
recommend
agenc
includ
cdc
avail
serolog
test
unclear
presum
test
develop
moreov
collect
submiss
sera
potenti
infect
patient
recommend
public
health
laboratori
cdc
issu
recommend
laboratori
safeti
test
specimen
patient
suspect
infect
guidelin
recommend
manipul
potenti
infecti
specimen
done
biosafeti
cabinet
potenti
splash
gener
droplet
aerosol
viral
isol
cultur
done
laboratori
test
chemistri
hematolog
laboratori
done
follow
routin
laboratori
precaut
recommend
work
current
promis
antivir
treatment
avail
howev
numer
compound
proven
effect
sarscov
merscov
test
wide
newli
emerg
remdesivir
chloroquin
found
highli
effect
vitro
control
infect
treatment
remdesivir
alon
combin
chloroquin
interferon
beta
found
effect
infect
strategi
caus
obviou
side
effect
yet
howev
investig
necessari
confirm
impact
remdesivir
coronavirus
share
key
genom
element
common
therapeut
target
like
greater
import
therapeut
agent
target
nucleosid
nucleotid
viral
nucleic
acid
enzymesprotein
involv
replic
transcript
coronavirus
promis
strategi
treat
coronaviru
diseas
tabl
surfac
spike
glycoprotein
import
potenti
target
antivir
agent
due
vital
role
interact
viru
cell
receptor
consist
two
subunit
aminotermin
receptor
bind
subunit
carboxytermin
membran
fusion
subunit
addit
activ
membran
fusion
viru
entri
requir
cleavag
junction
henc
subunittarget
monoclon
antibodi
subunittarget
fusion
inhibitor
may
effect
therapeut
agent
coronavirus
furin
serin
endoproteas
cleav
could
thu
suitabl
antivir
agent
helic
nucleocapsid
interact
protein
envelop
protein
membran
protein
form
assembl
virion
therefor
target
structur
gene
use
small
interf
rna
could
effect
therapeut
strategi
coronavirus
host
receptor
also
associ
viral
entri
host
cell
thu
agent
target
receptor
also
inhibit
coronavirus
inhibitor
endosom
cystein
proteas
transmembran
proteas
serin
partial
block
viral
entri
cell
target
membranebound
rna
synthesi
coronavirus
inhibit
doublemembran
vesicl
format
thu
could
effect
broadspectrum
antivir
dsrnaactiv
caspas
oligomer
draco
select
induc
apoptosi
viruscontain
host
cell
provid
anoth
class
evalu
effect
howev
class
provid
promis
strategi
alon
block
viru
entri
disrupt
viral
nucleic
acid
contrast
thiopurin
compound
naphthalen
inhibitor
proteas
inhibitor
zinc
mercuri
conjug
target
proteas
plpro
papainlik
proteas
enzym
coronavirus
shown
block
pathogen
therefor
combin
therapi
antivir
agent
draco
may
enhanc
overal
impact
recoveri
patient
despit
higher
rate
infecti
coronavirus
thought
abil
suppress
counteract
respons
host
innat
interferon
respons
augment
util
interferon
induc
recombin
interferon
recombin
interferon
interferon
alpha
interferon
beta
test
sarscov
might
util
either
alon
combin
potenti
antivir
drug
includ
remdesivir
interferon
alpha
beta
inhibit
viral
replic
use
interferon
induc
combin
effect
antivir
agent
worth
evalu
possibl
synergist
effect
addit
calcineurin
inhibitor
cyclosporin
combin
antibiot
tradit
chines
medicin
could
also
evalu
activ
effect
vaccin
import
prevent
control
sporad
viral
attack
emerg
virusmedi
epidem
recent
outbreak
caus
although
sarscov
fulli
control
merscov
prevent
caus
high
mortal
rate
newli
emerg
spread
effici
signific
increas
number
case
fatal
pass
day
vaccin
requir
prevent
caus
liveattenu
vaccin
design
sar
may
evalu
infect
patient
addit
rhesu
protein
cage
nanoparticl
innat
immunomodul
high
antisarscov
effici
base
high
similar
phylogenet
related
sarscov
protein
cage
nanoparticl
design
sarscov
evalu
meanwhil
follow
similar
strategi
util
sarscov
novel
protein
cage
nanoparticl
specifi
novel
coronaviru
design
emerg
basi
given
urgenc
current
scenario
outbreak
vaccin
strategi
base
viral
vector
recombin
protein
virallik
particl
develop
develop
sar
andor
mer
could
modifi
util
despit
current
progress
work
need
develop
safe
effect
vaccin
avail
individu
high
risk
endem
control
ongo
risk
futur
epidem
interest
featur
plasma
recov
patient
presenc
activ
antibodi
transfer
plasma
peopl
recov
infect
individu
might
enhanc
immun
monoclon
antibodi
could
inhibit
viruscel
receptor
bind
interrupt
viruscel
fusion
develop
combin
two
monoclon
antibodi
may
suitabl
quicker
recoveri
patient
lastli
antivir
peptid
target
differ
region
peptid
effect
viral
infect
also
consid
although
strategi
sarscov
develop
includ
receptorbind
domain
rbd
base
vaccin
requir
evalu
given
import
current
outbreak
wuhan
studi
need
deepen
understand
replic
pathogenesi
biolog
properti
use
revers
genet
relat
molecular
techniqu
investig
help
control
prevent
pneumonia
diseas
novel
emerg
diseas
futur
sarscov
merscov
report
origin
recombin
within
bat
virus
introduct
guangdong
provinc
civet
middl
east
camel
respect
sarscov
strain
becam
epidem
sever
independ
spillov
human
outbreak
guangdong
china
similarli
merscov
becam
epidem
seri
human
infect
middl
eastern
countri
virus
transfer
sever
countri
beyond
countri
origin
howev
unlik
continu
propag
merscov
epidem
sarscov
outbreak
success
control
base
origin
coronavirus
like
origin
bat
introduc
wuhan
china
unknown
intermedi
effect
clinic
treatment
prevent
strategi
avail
use
human
coronavirus
test
drug
coronavirus
requir
suitabl
anim
model
prior
use
human
current
establish
model
promis
studi
pathogenesi
treatment
highli
pathogen
coronavirus
instanc
nonhuman
primat
unabl
reproduc
characterist
sever
human
diseas
mortal
observ
howev
small
anim
develop
clinic
symptom
diseas
transgen
mice
express
human
mouseadapt
sarscov
strain
one
suitabl
model
addit
transgen
mice
express
human
suitabl
small
anim
model
mer
like
anim
model
sarscov
transgen
anim
model
may
also
standard
develop
clinic
drug
coronavirus
challeng
repeat
emerg
novel
coronavirus
divers
featur
thu
requir
specif
drug
newli
emerg
viru
moreov
limit
number
anim
model
avail
use
highli
demand
biosafeti
level
lab
perspect
current
outbreak
design
effect
therapeut
yet
anoth
challeng
scientist
although
larg
number
antivir
treatment
option
sar
mer
report
potent
vitro
activ
limit
number
may
potenti
clinic
set
move
forward
treatment
option
avail
could
util
clinic
ongo
epidem
broadspectrum
antivir
drug
may
effect
opportun
test
current
scenario
pneumonia
wuhan
china
broadrang
combin
therapi
includ
lopinavir
interferon
antivir
peptid
also
evalu
examin
agent
shown
signific
effect
mer
nonhuman
primat
design
develop
novel
broadspectrum
antivir
drug
potenti
target
coronavirus
may
prove
best
treatment
option
reemerg
circul
coronavirus
